Grand Rounds

Connecting the Dots: Deepening Our Understanding of Interstitial Lung Disease Associated with Connective Tissue Diseases

Department of Medicine Grand Rounds
-

Connecting the Dots: Deepening Our Understanding of Interstitial Lung Disease Associated with Connective Tissue Diseases

From nuanced patient care to emerging molecular pathways, this Medical Grand Rounds will demystify connective tissue disease-associated interstitial lung disease (CTD-ILD) and explore how cutting-edge genetics and clinical insights are converging to shape diagnostics and therapeutics. Through a discussion of early recognition, risk stratification, and personalized treatment strategies, attendees will learn practical tools to inform clinical practice.

Speakers:

Andrew Gross, MD, is professor and clinical chief of Rheumatology at UCSF Health and co-director of the UCSF Scleroderma Center. Gross works closely with UCSF physicians, immunology researchers, and specialists in the UCSF Interstitial Lung Disease Program to provide comprehensive care to patients with complex conditions.

Rupal Shah, MD, MS, is an associate professor and the medical director of adult patient experience in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health. She sees patients on the Lung Transplant and Interstitial Lung Disease services. Shah received the UCSF Exceptional Physician Award in 2022.

Anthony Shum, MD, is a professor in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health. His lab recently helped discover the genetic basis of COPA syndrome, an inherited autoimmune disorder that can lead to severe lung and joint disease. Shum also identified a novel lung-specific antigen that is targeted in patients with autoimmune lung disease and demonstrated that autoantibodies to this antigen could be used as a biomarker to detect patients with lung autoimmunity.

 

How to Attend

In Person:
S-214 (Medical Sciences Building) 
Lunch will be provided

On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/97645766587?pwd=OpxbkAwpMENJgLN8xpPHofjwzHD8JH.1
Webinar ID: 976 4576 6587
Passcode: 364678

By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 213 338 8477 or +1 669 219 2599
International numbers available: https://ucsf.zoom.us/u/abt1xcyvsc

The session will be recorded for later play. See all past recordings.

Add to Calendar 2025-04-29 19:00:00 2025-04-29 20:00:00 Connecting the Dots: Deepening Our Understanding of Interstitial Lung Disease Associated with Connective Tissue Diseases Connecting the Dots: Deepening Our Understanding of Interstitial Lung Disease Associated with Connective Tissue Diseases From nuanced patient care to emerging molecular pathways, this Medical Grand Rounds will demystify connective tissue disease-associated interstitial lung disease (CTD-ILD) and explore how cutting-edge genetics and clinical insights are converging to shape diagnostics and therapeutics. Through a discussion of early recognition, risk stratification, and personalized treatment strategies, attendees will learn practical tools to inform clinical practice. Speakers: Andrew Gross, MD, is professor and clinical chief of Rheumatology at UCSF Health and co-director of the UCSF Scleroderma Center. Gross works closely with UCSF physicians, immunology researchers, and specialists in the UCSF Interstitial Lung Disease Program to provide comprehensive care to patients with complex conditions. Rupal Shah, MD, MS, is an associate professor and the medical director of adult patient experience in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health. She sees patients on the Lung Transplant and Interstitial Lung Disease services. Shah received the UCSF Exceptional Physician Award in 2022. Anthony Shum, MD, is a professor in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health. His lab recently helped discover the genetic basis of COPA syndrome, an inherited autoimmune disorder that can lead to severe lung and joint disease. Shum also identified a novel lung-specific antigen that is targeted in patients with autoimmune lung disease and demonstrated that autoantibodies to this antigen could be used as a biomarker to detect patients with lung autoimmunity.   How to Attend In Person: S-214 (Medical Sciences Building)  Lunch will be provided On Zoom: Join from a PC, Mac, iPad, iPhone or Android device: https://ucsf.zoom.us/j/97645766587?pwd=OpxbkAwpMENJgLN8xpPHofjwzHD8JH.1 Webinar ID: 976 4576 6587 Passcode: 364678 By Phone (for higher quality, dial a number based on your current location): US: +1 669 900 6833 or +1 213 338 8477 or +1 669 219 2599 International numbers available: https://ucsf.zoom.us/u/abt1xcyvsc The session will be recorded for later play. See all past recordings. Department of Medicine America/Los_Angeles public